Deoxynivalenol and male reproductive toxicity: Unraveling the hidden risks

Ana Laura Paulino Leite Gomes1, Glaura Scantamburlo Alves Fernandes2, Ana Paula Frederico Rodrigues Loureiro Bracarense1

  • 1Laboratory of Animal Pathology, Universidade Estadual de Londrina, Rodovia Celso Garcia Cid, km 380, Londrina, Paraná 86057-970, Brazil.

Toxicology
|May 18, 2025
PubMed

Insights

Deoxynivalenol (DON) exposure negatively impacts male reproductive health by affecting sperm quality and quantity. Parental DON exposure also leads to adverse offspring development, confirming its toxic effects.

Area of Science:

  • Toxicology
  • Reproductive Biology
  • Environmental Health

Background:

  • Deoxynivalenol (DON) is a widespread mycotoxin with known gastrointestinal and immune effects.
  • Emerging evidence suggests DON also impairs male reproductive function.
  • Understanding DON's reproductive toxicity is crucial for public health.

Purpose of the Study:

  • To review current evidence on DON's impact on male reproductive organs.
  • To emphasize DON's effects on hormonal balance, germinal epithelium, and the blood-testis barrier.
  • To explore DON's effects on accessory reproductive organs and offspring development.

Main Methods:

  • Comprehensive literature review of studies investigating DON's effects on male reproduction.
  • Analysis of mechanisms including oxidative stress, inflammation, and apoptosis.
  • Evaluation of studies on parental DON exposure and subsequent offspring outcomes.

Main Results:

  • DON disrupts hormonal regulation, damages the germinal epithelium, and compromises the blood-testis barrier.
  • Oxidative stress, inflammation, and apoptosis are key mechanisms mediating DON's toxicity.
  • Reduced sperm quality and quantity, impaired epididymis, prostate, and seminal vesicle function were observed.
  • Parental DON exposure adversely affects offspring development across various stages.

Conclusions:

  • Deoxynivalenol poses a significant threat to male reproductive health.
  • DON-induced alterations lead to impaired fertility and potential transgenerational effects.
  • Further research is warranted to fully elucidate DON's reproductive toxicology and its implications.

Related Concept Videos

Hypothesis: Accept or Fail to Reject?01:17

Hypothesis: Accept or Fail to Reject?

The outcome of any hypothesis testing leads to rejecting or not rejecting the null hypothesis. This decision is taken based on the analysis of the data, an appropriate test statistic, an appropriate confidence level, the critical values, and P-values. However, when the evidence suggests that the null hypothesis cannot be rejected, is it right to say, 'Accept' the null hypothesis?
There are two ways to indicate that the null hypothesis is not rejected. 'Accept' the null...
27.4K
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.6K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K